Emsurg Healthcare (India) Pvt. Ltd., headquartered in Kolkata, is a leading medical device company dedicated to advancing healthcare solutions across India. Since our inception in 2010, we have grown from our early focus on biologics, vertebroplasty, and kyphoplasty to becoming a trusted partner for global medical technology leaders. Our state-of-the-art manufacturing facility produces hemodialysis fluids, dry citrate powder, and orthobiologics, ensuring high-quality, reliable products for healthcare professionals.
Complementing our indigenous manufacturing, we import and distribute advanced devices such as biopsy niddles and radiopaque bone cements, enabling hospitals and clinics to access world-class medical technology. Guided by innovation, research, and ethical excellence, Emsurg Healthcare continues to deliver solutions that improve patient outcomes, empower medical professionals, and redefine standards in modern healthcare.
To drive innovation and excellence in healthcare by delivering high-quality medical devices, advanced biomaterials, and reliable solutions that improve patient outcomes and empower healthcare professionals. We are committed to maintaining the highest standards of safety, quality, and ethical practice while continuously developing technologies that address evolving clinical challenges across India and globally.
To become a globally recognized, professionally managed medical technology company that expands the possibilities of healthcare. We aim to lead through innovation, collaboration, and ethical business practices while fostering a culture of excellence, meritocracy, and sustainable growth. Our vision is to empower medical professionals and institutions with advanced solutions that set new benchmarks in patient care and clinical efficiency.
Emsurg was founded in 2010, initially operating in biologics, vertebroplasty, and kyphoplasty, laying the foundation for expertise in advanced medical procedures.
In 2012, Emsurg became a channel partner of Smith & Nephew, a global leader in sports medicine, bringing minimally invasive joint surgery technologies to India.
Emsurg gained exclusive import rights for spine bone cement and biopsy devices from Teknimed and MDL, establishing itself as a trusted partner for leading medical firms.
In 2020, Emsurg established a state-of-the-art production facility in Kolkata for dry citrate powder and hemodialysate, marking the start of domestic manufacturing excellence.
Emsurg expanded its portfolio in 2023 to include wound care materials and orthopedic biologics, broadening its impact in advanced healthcare solutions.
By 2024, Emsurg began producing and marketing innovative medical devices, including negative pressure wound therapy machines, strengthening its role in patient-centered healthcare.
Emsurg Healthcare takes pride in serving a diverse portfolio of clients, including leading hospitals, healthcare institutions, and medical professionals across India. Through our commitment to quality, innovation, and reliable service, we have built long-term partnerships that empower our clients to deliver exceptional patient care and advance healthcare standards nationwide.
